November 08, 2018
Interim report July-September 2018
Media
November 07, 2018
Modus Therapeutics announces FDA Acceptance of Sevuparin IND for treatment of sickle cell disease
November 07, 2018
MIPS INTERIM REPORT JANUARY – SEPTEMBER 2018
November 07, 2018
BONESUPPORT HOLDING AB (publ) – Interim Report
November 06, 2018
Nordic Nanovector ASA: Results for the Third Quarter 2018
November 05, 2018
Additional steps towards the commercialization of Ygalo®
November 05, 2018
EXTRAORDINARY GENERAL MEETING IN ONCOPEPTIDES AB (PUBL)
November 05, 2018
Strongbridge Biopharma plc to Present at the Stifel 2018 Healthcare Conference
November 02, 2018
Nordic Nanovector Announces First Patient Dosed in Archer-1 Trial of Betalutin® plus Rituximab in Follicular Lymphoma
November 01, 2018
Vicore Pharma’s rights issue registered – conversion of BTA to shares